KURA ONCOLOGY, INC. (KURA) valuation

Share price $8.13 · As of last filing 2026-03-31

Price-to-Earnings

P/E · Trailing Diluted

-2.43×

P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing

-8.55×

P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing

-11.70%

FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing

-0.52×

EV/EBITDA history →

Underlying EBIT Margin

EBIT + SBC · Trailing

-390.94%

Methodology →

Price-to-Sales

P/S · Trailing

10.07×

P/S history →

Price-to-Book

P/B · Latest filing

6.69×

P/B history →

Special situation detected — historical normalisation may not reflect go-forward economics. EPV and Reverse-DCF outputs below are anchored on history that no longer represents the entity going forward (net cash > 50% of market cap) . Inspect the balance sheet, recent 8-K filings, and the cards above before relying on these models.

net cash > 50% of market cap. Net cash $556.5M (cash $580.8M − debt $24.3M) = 77.1% of market cap $721.7M

Related tickers

CSPI

CSP Inc

MG

Mistras Group, Inc.

TTEC

TTEC Holdings, Inc.